ArticleThe Lancet. Rheumatology2020

Tocilizumab in COVID-19: finding the optimal route and dose - Authors' reply.

Giovanni Guaraldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.